Empresa Imprimis Pharmaceuticals Inc Nasdaq
Acciones
US45323A2015
Farmacéuticos
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Ophthalmic Therapies
100,0
%
| 89 | 100,0 % | 130 | 100,0 % | +46,95 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 89 | 100,0 % | 130 | 100,0 % | +46,95 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 01/01/06 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 01/12/11 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Kim Barratt
HRO | Human Resources Officer | - | 01/07/22 |
Dennis E. Saadeh
PRN | Corporate Officer/Principal | - | - |
Mark Mannebach
LAW | General Counsel | - | 06/03/23 |
John Saharek
PRN | Corporate Officer/Principal | 64 | 01/11/12 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 01/01/06 |
Director/Board Member | 65 | 26/01 | |
Adrienne Graves
BRD | Director/Board Member | 69 | 26/01 |
Teresa Sparks
BRD | Director/Board Member | 55 | 16/03/20 |
Director/Board Member | 55 | 31/03/22 | |
Marty Makary
BRD | Director/Board Member | 53 | 31/03/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 35 381 611 | 30 223 137 ( 85,42 %) | 0 | 85,42 % |
Información de la empresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+21,85 % | 546 mil M | |
-4,77 % | 359 mil M | |
+16,97 % | 323 mil M | |
+5,69 % | 290 mil M | |
+13,68 % | 234 mil M | |
+3,65 % | 198 mil M | |
-11,12 % | 194 mil M | |
+8,08 % | 167 mil M | |
-3,40 % | 157 mil M |